ClinicalTrials.gov record
Recruiting Not applicable Interventional

REMASTer: REcurrent Brain Metastases After SRS Trial

ClinicalTrials.gov ID: NCT05124912

Public ClinicalTrials.gov record NCT05124912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 4:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05124912
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Monteris Medical
Industry
Enrollment
261 participants

Conditions and interventions

Interventions

  • Laser Interstitial Thermal Therapy Procedure
  • Radiation Therapy Procedure
  • Steroid Therapy Drug

Procedure · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 9, 2022
Primary completion
Nov 30, 2026
Completion
Sep 30, 2028
Last update posted
Feb 19, 2026

2022 – 2028

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
UCLA Los Angeles California 90095 Recruiting
University of Chicago Chicago Illinois 60637 Recruiting
University of Maryland Baltimore Maryland 21201 Recruiting
WashU St Louis Missouri 63130 Recruiting
Duke University Hospital Durham North Carolina 27710 Active, not recruiting
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157 Recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
Kettering Health Kettering Ohio 45429 Recruiting
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05124912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2026 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05124912 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →